Modulation of aerosol clouds produced by pressurised inhalation aerosols

G. Brambilla, D. Ganderton, R. Garzia, D. Lewis, B. Meakin, P. Ventura

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

The inclusion of non-volatile components such as glycerol or polyethylene glycol in hydrofluoralkane (HFA) solution formulations for pressurised metered dose inhalers (pMDIs), greatly increases the particle size of the aerosol. Cloud characteristics can be further modulated by permuting this factor with the choice of propellant and the dimensions of the actuator, to give a chosen fine particle dose and particle diameter. This principle has been used to design solutions which closely match the performance of chlorofluorocarbon based suspension formulations containing beclomethasone dipropionate, budesonide and ipratropium bromide as assessed for pharmaceutical equivalence using the Andersen Cascade impactor.
Original languageEnglish
Pages (from-to)53-61
Number of pages9
JournalInternational Journal of Pharmaceutics
Volume186
Issue number1
DOIs
Publication statusPublished - 10 Sep 1999

Fingerprint

Aerosols
Inhalation
Chlorofluorocarbons
Ipratropium
Beclomethasone
Metered Dose Inhalers
Budesonide
Particle Size
Glycerol
Suspensions
Pharmaceutical Preparations

Keywords

  • Aerosols
  • Chlorofluorocarbons
  • Hydrocarbons, Fluorinated
  • Nebulizers and Vaporizers

Cite this

Brambilla, G., Ganderton, D., Garzia, R., Lewis, D., Meakin, B., & Ventura, P. (1999). Modulation of aerosol clouds produced by pressurised inhalation aerosols. International Journal of Pharmaceutics, 186(1), 53-61. https://doi.org/10.1016/S0378-5173(99)00137-4

Modulation of aerosol clouds produced by pressurised inhalation aerosols. / Brambilla, G.; Ganderton, D.; Garzia, R.; Lewis, D.; Meakin, B.; Ventura, P.

In: International Journal of Pharmaceutics, Vol. 186, No. 1, 10.09.1999, p. 53-61.

Research output: Contribution to journalArticle

Brambilla, G, Ganderton, D, Garzia, R, Lewis, D, Meakin, B & Ventura, P 1999, 'Modulation of aerosol clouds produced by pressurised inhalation aerosols', International Journal of Pharmaceutics, vol. 186, no. 1, pp. 53-61. https://doi.org/10.1016/S0378-5173(99)00137-4
Brambilla, G. ; Ganderton, D. ; Garzia, R. ; Lewis, D. ; Meakin, B. ; Ventura, P. / Modulation of aerosol clouds produced by pressurised inhalation aerosols. In: International Journal of Pharmaceutics. 1999 ; Vol. 186, No. 1. pp. 53-61.
@article{ec5dc695787244d4a2b8315939db52e8,
title = "Modulation of aerosol clouds produced by pressurised inhalation aerosols",
abstract = "The inclusion of non-volatile components such as glycerol or polyethylene glycol in hydrofluoralkane (HFA) solution formulations for pressurised metered dose inhalers (pMDIs), greatly increases the particle size of the aerosol. Cloud characteristics can be further modulated by permuting this factor with the choice of propellant and the dimensions of the actuator, to give a chosen fine particle dose and particle diameter. This principle has been used to design solutions which closely match the performance of chlorofluorocarbon based suspension formulations containing beclomethasone dipropionate, budesonide and ipratropium bromide as assessed for pharmaceutical equivalence using the Andersen Cascade impactor.",
keywords = "Aerosols, Chlorofluorocarbons, Hydrocarbons, Fluorinated, Nebulizers and Vaporizers",
author = "G. Brambilla and D. Ganderton and R. Garzia and D. Lewis and B. Meakin and P. Ventura",
year = "1999",
month = "9",
day = "10",
doi = "10.1016/S0378-5173(99)00137-4",
language = "English",
volume = "186",
pages = "53--61",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Modulation of aerosol clouds produced by pressurised inhalation aerosols

AU - Brambilla, G.

AU - Ganderton, D.

AU - Garzia, R.

AU - Lewis, D.

AU - Meakin, B.

AU - Ventura, P.

PY - 1999/9/10

Y1 - 1999/9/10

N2 - The inclusion of non-volatile components such as glycerol or polyethylene glycol in hydrofluoralkane (HFA) solution formulations for pressurised metered dose inhalers (pMDIs), greatly increases the particle size of the aerosol. Cloud characteristics can be further modulated by permuting this factor with the choice of propellant and the dimensions of the actuator, to give a chosen fine particle dose and particle diameter. This principle has been used to design solutions which closely match the performance of chlorofluorocarbon based suspension formulations containing beclomethasone dipropionate, budesonide and ipratropium bromide as assessed for pharmaceutical equivalence using the Andersen Cascade impactor.

AB - The inclusion of non-volatile components such as glycerol or polyethylene glycol in hydrofluoralkane (HFA) solution formulations for pressurised metered dose inhalers (pMDIs), greatly increases the particle size of the aerosol. Cloud characteristics can be further modulated by permuting this factor with the choice of propellant and the dimensions of the actuator, to give a chosen fine particle dose and particle diameter. This principle has been used to design solutions which closely match the performance of chlorofluorocarbon based suspension formulations containing beclomethasone dipropionate, budesonide and ipratropium bromide as assessed for pharmaceutical equivalence using the Andersen Cascade impactor.

KW - Aerosols

KW - Chlorofluorocarbons

KW - Hydrocarbons, Fluorinated

KW - Nebulizers and Vaporizers

UR - http://dx.doi.org/10.1016/S0378-5173(99)00137-4

U2 - 10.1016/S0378-5173(99)00137-4

DO - 10.1016/S0378-5173(99)00137-4

M3 - Article

VL - 186

SP - 53

EP - 61

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1

ER -